Rates of Condom use among HIV Positive Patients on
ART in Nasarawa Eggon North Central Nigeria

Joseph E Enegela; Ochanya Iyaji Paul; Olanrewaju Olaiya; Edward Ugba; Patrick Okoh; Olufunmilayo Ogundeko; Ayodele Fagbemi; Oladipo Akinmade; Iko Ibanga; Amana Effiong

info@biomedres.us +1 (720) 414-3554

One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA

Biomedical Journal of Scientific & Technical Research

June, 2019, Volume 18, 5, pp 13842-13847

Research Article

Rates of Condom use among HIV Positive Patients on ART in Nasarawa Eggon North Central Nigeria

Joseph E Enegela*, Ochanya Iyaji Paul, Olanrewaju Olaiya, Edward Ugba, Patrick Okoh, Olufunmilayo Ogundeko, Ayodele Fagbemi, Oladipo Akinmade, Iko Ibanga and Amana Effiong

Author Affiliations

Pro-Health International, IPSAN project, Nigeria

Received: June 03, 2019 | Published: June 11, 2019

Corresponding author: Joseph E Enegela, Pro-Health International, IPSAN project, Nigeria

DOI: 10.26717/BJSTR.2019.18.003201

Also View In:

Abstract

Introduction: Consistent condom use still remains a key strategy in HIV prevention. Studies have demonstrated declining condom use among HIV positive patients on ART. There is paucity of such information among HIV positive individuals on ART in Nigeria. We sought to find the rates and associated factors for condom use among a cohort of PLHIV on ART in Nigeria.

Methods: A cross sectional review of PLHIV on ART was carried out in an ART treatment facility. Trained clinic staff administered a checklist to adult patients who had been on ART for a minimum of 9 months. Information was collected on age, sex, marital status, number of sexual partners, condom use and occurrence of sexually transmitted infection.

Results: Of the 282 respondents; average age was 35 years. Forty four percent (44%) never used while 25% used condoms consistently in the previous 3 months. Single (OR: 7.23, CI: 2.999-17.446, p= 0.000) and widowed (OR: 3.76, CI-1.179-12.04, p= 0.026) respondents were more likely to use condom always or sometimes. Male respondents were almost twice as likely to use condoms always and sometimes (OR: 1.74, CI-0.988-3.078, p = 0.055). There was no significant association between condom use and history of STI (OR: 0.74, CI-0.444-1.239, p= 0.254), or number of sexual partners (OR: 0.93, CI-0.427-2.01, p = 0.848).

Conclusion: Rates of condom use was low particularly among females and married patients on ART. Program and clinic managers should aggressively target females and married couples with varied and appropriate prevention messaging to improve coverage.

Keywords: ART; Condom, HIV

Introduction

The global picture of the HIV epidemic has continued to show evidence of impact of the social, biomedical and behavioral HIV prevention strategies [1], with new HIV infections dropping to 2.1 million in 2015 [2] from 5 million in 2001 [3]. In Nigeria, the number of new infections was reported to have reduced by about 24% in the same period [2]. Much of this progress however seems to have happened in the period prior to 2010 as between that year and 2015, only about 100,000 new HIV infections were reported [2]. Although there are several others, some of the important factors that could have affected the slowing of this progress include the stall in condom provision and use with an over 50% condom gap in sub-Saharan Africa [1]; persistent socio-cultural barriers including gender inequality, refusal to use in marriage, and vaginal douching [4,5], all which predate the gap in provision of condoms. Condom use has been severally demonstrated to contribute significantly to attenuating sexual transmission of HIV and is therefore an important factor in the control and eradication of the virus. Condom use was shown to reduce transmission risk 20 fold in a study that quantified per act risk of transmission on a basis of various risk factors [6] while in another study of 17, 450 sexually active individuals in Uganda; condom use significantly reduced the incidence of HIV infection [7].

Furthermore, a recent meta-analysis on per-act risk of HIV transmission demonstrated a 99.2% attenuation of HIV acquisition risk when there is a dual use of condom and ART in the HIV positive individual [8]. While some studies have shown a positive adjustment in sexual risk behavior after commencing ART [9], others have shown a condom fatigue and consequent negative adjustment in risky sexual behavior over the long term [10,11]. In Nigeria, 38% of all sexually active respondents in a national reproductive health survey had ever used male condoms, out of which 54% are current users (defined as condom use in the preceding 12 months with the proportion of females respondents being less than their male counterparts) [12]. Information on condom use rate among patients on ART in Nigeria is sparse and varied with no clear pattern. Reports from South Western Nigeria found a very low condom use rate among HAART naïve (13%) and experienced (16%) clients respectively, with consistent use being more likely among females [13]; a condom use rate of 75.9% with a more likely prevalence among males, singles and those with formal education [14] and a third reported a condom use rate of 53.8% among patients on ART, 12 months after commencing treatment, with married clients being more likely to use condoms [15]. These coupled with the few number of studies, the variability in factors thought to contribute to higher condom use rates and the differences in HIV/AIDS prevalence across the country further indicates that studies are required in this area, especially from population not previously studied in this regards. In this study, we sought to examine the rate of condom use and associated factors among a cohort of HIV positive patients on ART.

Methods

Study Location

Nasarawa Eggon General hospital, based in Nasarawa Eggon Local Government Area, is a secondary health facility that has been providing care for people living with HIV since 2004. It is located in Nasarawa, one of the six states in the north central region of Nigeria with an HIV prevalence of 8.1% [12]. As a local government-level facility, it has a catchment of about 148,402 population [16] and an additional unknown transit population as the town sits on a major transit corridor between the north and the south of the country. With funding from the USG/PEPFAR through the Centers for Diseases Control and Prevention, it is the only facility providing comprehensive HIV/AIDS care, prevention and treatment services in the local government area. Patients also receive condoms free of charge both within the community through community-based organizations and from designated health care workers within the facility.

Study Sample and Procedure

This was cross sectional study of 392 randomly selected patients from a total 995 on antiretroviral therapy that visited the hospital in July 2015. These are HIV positive patients of either sex who are a minimum of sixteen years of age and had been on Antiretroviral therapy for at least 9 months at the time of the review. There was no discrimination on basis of patient regimen type. The review included evaluation of clinical management histories as well as immunological and virologic laboratory results. Prior to the commencement of the review, patients’ care teams were trained on the process and the administration of select tools. In addition, eligible clients were administered a checklist to assess their level of treatment adherence, adherence to lifestyle changes, as well as evaluation of the social support structure available to them. The checklist also collected information on age and sex of respondents, marital status, number of sexual partners, history of sexually transmitted infection in the preceding 12 months and history of condom use in the preceding 3 months.

We defined condom use as the use of either male or female condom by either partner during sexual intercourse in the preceding 3 months. Condom use responses were graded into those who “always” correctly and consistently used condom during all sexual encounters, those who “never” used, and those who use “some of the times”. Patients who were not sexually active during the period were categorized as “not applicable”. We ascertained history of STI by asking history of genitourinary discharge, genital ulcers, history of STI diagnosis and/or treatment; patients were required to answer yes or no to the presence of any or all the symptoms. Marital status of patients where categorized into married, divorced or separated, widowed and single. Trained adherence counselors and nurses administered the checklist to all eligible patients. The sample size was determined using a 99% confidence level assuming 0.5 proportion. The sample was then drawn randomly from the pool of administered checklist.

Data Analysis

Data from the checklist was transferred into a Microsoft Excel for coding, anonymization and cleaning. Further analysis was done using STATA version 14, StataCorp. 2015. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP. Sociodemographic characteristics were expressed in simple percentages while Pearson’s Chi square test was used to test for association between some of the demographic information and condom use rate in a bivariate analysis while a multivariate ordinal logistic regression was used to test the strength and direction of the association. Statistically significant association was accepted at p<0.05 and 95% confidence interval (CI). Ethical clearance for the review was received from the Nigerian National Health Research Ethics Committee under a non-research determination exemption for public health activities. NHREC approval number NHREC/01/01/2007-14/10/2015.

Results

After correcting for missing data, inappropriate and declined responses, 282 were included for the analysis and a further 35 respondents who did not have any sexual partner were excluded from the regression analysis as they were unlikely to use condoms. Table 1 describes the population characteristics; the average age in the group was 35 years with a median of 33 (SD 9.59). Most of the respondents (45%; 128) were between the ages of 25 and 34, while 20% were 45 years and above (Figure 1). Approximately 67% of the respondents were females, 72% (202) were married while 13% (36) and 10% (28) were single and widowed respectively. Forty-four percent of the respondents never use condom during sexual intercourse, while 31% (86) and 25% (69) use condoms “sometimes” or “always” respectively. Furthermore, most respondents (77%; 128) had only one sexual partner while only 10% had multiple sexual partners. Sixty two percent (176) had no history of sexually transmitted infections. On marital status, thirty eight percent (38%) of divorced/separated respondents, 42% of the married, 11% and 18% of the single and widowed respondents respectively never used condoms during sexual intercourse in the previous three months.

Figure 1:

Table 1: Population Characteristics.

In a bivariate analysis (Table 2), we found a significant relationship [p = 0.001] between marital status and condom use. There was no significant relationship between condom use and age (p= 0.837). On further analysis using a multivariate ordinal regression model (Table 3) we found that single (OR: 7.23, CI: 2.999-17.446, p= 0.000) and widowed (OR: 3.76, CI-1.179-12.04, p= 0.026) respondents were more likely to use condom “always” or “sometimes” when compared with married couples. Male respondents were almost twice as likely to use condoms always and sometimes as their female counterparts (OR: 1.74, CI-0.988- 3.078, p = 0.055). No significant association was found in condom use between respondents who had history of STI and those who didn’t (OR: 0.74, CI-0.444-1.239, p= 0.254), or between those who had multiple sexual partners and those with one sexual partner (OR: 0.93, CI-0.427-2.01, p = 0.848).

Table 2: Bivariate Relationship between characteristics and condom use.

Table 3: Multivariate Ordinal Logistic Regression Model.

Discussion

Despite the proven effect of ART as a strategy in HIV prevention, the use of condoms has continued to be an important component of preventing HIV and other STIs and therefore remains integral in the combination prevention [1] strategy. Only 25% of the respondents in our study always used and 44% never used condoms during sexual intercourse. This is at variance with a study from western Nigeria where consistent and correct use of condoms was seen in 75% of the study participants [14]. A second study from Western Nigeria went further to demonstrate a change in condom use rates between a pre ART rate of 14.0% and a post ART rate of 43.3%. [15] It is however consistent with other studies including one from South Eastern Nigeria that demonstrated low rates of condom use [17-19]. These reported low rates of consistent use of condoms are important when considered against the backdrop of poor adherence, which eventually negates the preventive effect of ART. Although we did not evaluate the effect of condom availability on its use or lack of, it is instructive to state that even when individuals have the means to purchase condoms, studies have demonstrated issues like low risk perception and lack of motivation as factors that contribute to non-usage [20]. A second factor may be the effect of human resource challenges on the ability of health care workers to continually deliver care; including ART scale up and accurate condom messaging to PLHIV attending clinics [21,22]. Our analysis also showed that men were twice as likely to use condom always or sometimes. This may be due to male dominance in relationships in Nigeria, lower likelihood for women to negotiate safe sexual practices [23,24], coupled with poor uptake of female condoms occasioned by unavailability, cost and difficulty in insertion [25,26]. We are aware that female condoms are however not popular in the target facility due to limited supplies and a general apathy among health workers towards female condom counseling.

Single and widowed respondents showed very high likelihood of using condoms sometimes or always when compared to married couples. The observation was similar to other studies that demonstrated low rates of condom use among married couples [27]. This may be due to a reduced risk perception seeing that they are in a ‘stable’ relationship or with someone they trust; with or without concordance, and a lack of disclosure may also be a significant factor as observed in some studies [28,29]. Furthermore, as patients get healthier, their desire to have children has been shown to invariably influence condom use [29,30]. It could also be argued that the single and widowed do not have stable relationships, and are therefore more mindful of getting infected with ‘other’ subtypes of the virus or STIs. It could further be that the health care workers in the clinic have targeted single and widowed PLHIVs more with prevention and condom messages than they have married couples. All the above notwithstanding, a study has demonstrated patients in a marital union where more likely to use condom during sex [15]. Some of the limitations of the study included a possible role of culture and norms that may limit appropriate responses from female respondents. The study did not explore the reasons behind condom use choices but we acknowledge the importance of this added information in understanding individual reasons for choices; this may be the subject of future research.

Conclusion

Considering the central importance of the direct and indirect impact of condom messaging in the overall HIV prevention strategy, the need to promote higher condom use in our setting is nigh. Program managers must design better ways of keeping the appropriate condom messaging on the front burner of care and prevention services among HIV positive patients on ART with increased focus on females and married couples.

Acknowledgement

This publication was made possible with funding support from the HHS/Centers for Disease Control and Prevention (CDC) cooperative agreement number GH000929. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the United States (U.S.) Centers for Disease Control and Prevention. Use of trade names is for identification only and does not imply endorsement by the U.S. Centers for Disease Control and Prevention or the U.S. Department of Health and Human Services. The authors will also like to thank Raphael Akpan and Aminu Yakubu of CDC for their valuable inputs during this work and completion of the manuscript.

References